+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with non-small-cell lung cancer: a study of 2062 cases



Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with non-small-cell lung cancer: a study of 2062 cases



British Journal of Radiology 88(1056): 20140288



To study the pattern of lymph node metastasis (LNM) of non-small-cell lung cancer (NSCLC) and to clarify which node level should be included while undergoing radiotherapy (RT). A total of 2062 patients with NSCLC patients who had undergone thoracotomy were retrospectively examined. The clinicopathological factors related to LNM were analysed. The LNM rates (the number of node-positive patients/the total number of patients) in patients with primary tumours in different lobes (left upper lobe, left lower lobe, right upper lobe, right middle lobe and right lower lobe) were 53.25%, 53.87%, 53.77%, 64.67% and 61.58%, respectively. We have found that in all of the clinicopathological factors, including sex, age, tumour location, histological type, maximum diameter, T stage, degree of differentiation and tumour growth pattern, only maximum diameter (p = 0.336) and histological type (p = 0.360) did not have significant correlation with LNM rate. All of the above factors except tumour growth pattern (p = 0.239) and maximum diameter (p = 0.613) were significantly associated with lymph node ratio [LNR, ratio between metastatic and examined lymph nodes (LNs)] in linear regression. For patients with NSCLC, LNM rate and LNR can be recommended as applicable parameters for LN involvement. Multiple clinicopathological factors should be considered comprehensively to design the clinical target volume for RT of NSCLC. This article can provide evidence to radio-oncologists how to choose range of lymph nodal clinical target volume when they are treating inoperable patients with NSCLC patients by analysing data of patients after surgery.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058515973

Download citation: RISBibTeXText

PMID: 26126020

DOI: 10.1259/bjr.20140288


Related references

Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases. RadioTherapy and Oncology 95(2): 229-233, 2010

Distribution pattern of lymph node metastases and its implication in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with stage IA to IIA cervical cancer. Radiation Oncology 10: 40, 2015

Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume delineation of regional lymph node in patients with gastric carcinoma. RadioTherapy and Oncology 96(2): 223-230, 2010

Pattern of Lymph Node Metastases and Its Implication for Radiotherapeutic Clinical Target Volume in Patients With cN0 Supraglottic Carcinoma: Ipsilateral or Bilateral Neck Irradiation. International Journal of Radiation Oncology*biology*physics 99(2): E385-E386, 2017

Exploration of the Radiotherapeutic Clinical Target Volume Delineation for Gastric Cancer from Lymph Node Metastases. Anticancer Research 37(8): 4629-4634, 2017

Preliminary study of F-18-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients. Zhonghua Zhongliu Zazhi 29(6): 453-456, 2007

Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score. Journal of Thoracic and Cardiovascular Surgery 139(4): 1001-1006, 2010

Reduced irradiation target volume of mediastinal lymph node drainage in conformal radiotherapy for patients with non-small cell lung cancer after thoracic surgery. Nan Fang Yi Ke Da Xue Xue Bao 27(8): 1224-1226, 2007

Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases. Journal of Thoracic Disease 7(12): 2313-2320, 2015

Exploration of lymph node metastasis and appropriate lymph node dissection modes in patients with clinical stage I non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 36(7): 536-540, 2014

A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. British Journal of Radiology 85(1019): E1110, 2012

Explore the radiotherapeutic clinical target volume delineation for thoracic esophageal squamous cell carcinoma from the pattern of lymphatic metastases. Journal of Thoracic Oncology 8(3): 359-365, 2013

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. Journal of Clinical Oncology 16(6): 2142-2149, 1998

Metastatic characteristics of lymph node in supraclavicular zone and radiotherapy target volume for limited-stage small cell lung cancer. Zhonghua Yi Xue Za Zhi 93(19): 1476-1478, 2013

Clinical significance of intranodal and extranodal growth in lymph node metastases of non-small cell lung cancer. ScandinavianJournalofThoracicandCardiovascularSurgery28(3-4):97, 1994